Xavier Guille des Buttes

Delpharm Holding SASU was engaged in pharmaceutical development and contract manufacturing services. Its activities included secondary manufacturing and processing, packaging and labeling of finished products, and branded prescription products. The company was founded on March 29, 2011 and was headquartered in Boulogne-Billancourt, France.

Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France.

IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium.

DIAGAST SAS operates as a blood matching company. Its products include QWALYS range, Erythrocytes Magnetized technology, manual range, PK 7300 ranges, pre-transfusion control, disposable plates and technical inserts. The company was founded in 1968 and is headquartered in Loos, France.

Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France.

Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France.